Combining multimodal imaging and treatment features improves machine learning-based prognostic assessment in patients with glioblastoma multiforme

Treatment-related features improve machine learning prediction of prognosis in soft tissue sarcoma patients

(2018) Jan C. Peeken et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK)

(2018) Stephanie E. Combs et al.   Cancer Medicine

Radiomic MRI Phenotyping of Glioblastoma: Improving Survival Prediction

(2018) Sohi Bae et al.   RADIOLOGY

Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives

(2017) Wojciech Szopa et al.   Biomed Research International

A combinatorial radiographic phenotype may stratify patient survival and be associated with invasion and proliferation characteristics in glioblastoma

(2016) Arvind Rao et al.   JOURNAL OF NEUROSURGERY

Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma

(2016) Sina Burth et al.   NEURO-ONCOLOGY

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009–2013

(2016) Quinn T. Ostrom et al.   NEURO-ONCOLOGY

Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models

(2016) Philipp Kickingereder et al.   RADIOLOGY

MR Perfusion–derived Hemodynamic Parametric Response Mapping of Bevacizumab Efficacy in Recurrent Glioblastoma

(2016) Philipp Kickingereder et al.   RADIOLOGY

Radiomics in glioblastoma: current status, challenges and potential opportunities

(2016) Shivali Narang et al.   Translational Cancer Research

Textural analysis of pre-therapeutic [18F]-FET-PET and its correlation with tumor grade and patient survival in high-grade gliomas

(2015) Thomas Pyka et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

18F-fluoro-ethyl-tyrosine positron emission tomography for grading and estimation of prognosis in patients with intracranial gliomas

(2015) Jens Gempt et al.   EUROPEAN JOURNAL OF RADIOLOGY

Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM

(2015) B. Suchorska et al.   NEUROLOGY

Random survival forests for competing risks

(2014) H. Ishwaran et al.   BIOSTATISTICS

Prognostic Significance of Dynamic 18F-FET PET in Newly Diagnosed Astrocytic High-Grade Glioma

(2014) N. L. Jansen et al.   JOURNAL OF NUCLEAR MEDICINE

RESULTS OF THE INTERNATIONAL INTERLABORATORY COMPARISON OF MGMT PROMOTER METHYLATION ANALYSIS INVOLVING TWENTY-THREE ACADEMIC CENTERS IN GERMANY, AUSTRIA AND THE NETHERLANDS

(2014) G. Reifenberger et al.   NEURO-ONCOLOGY

Imaging descriptors improve the predictive power of survival models for glioblastoma patients

(2013) M. A. Mazurowski et al.   NEURO-ONCOLOGY

MR Imaging Predictors of Molecular Profile and Survival: Multi-institutional Study of the TCGA Glioblastoma Data Set

(2013) David A. Gutman et al.   RADIOLOGY

Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma

(2012) Stephanie E. Combs et al.   ACTA ONCOLOGICA

Predicting outcomes in radiation oncology—multifactorial decision support systems

(2012) Philippe Lambin et al.   Nature Reviews Clinical Oncology

A Novel Volume-Age-KPS (VAK) Glioblastoma Classification Identifies a Prognostic Cognate microRNA-Gene Signature

(2012) Pascal O. Zinn et al.   PLoS One

Predictive impact of MGMT promoter methylation in glioblastoma of the elderly

(2011) Guido Reifenberger et al.   INTERNATIONAL JOURNAL OF CANCER

Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back?

(2011) Stephanie E Combs et al.   Radiation Oncology

Prognostic impact of postoperative, pre-irradiation 18F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy

(2011) Marc D. Piroth et al.   RADIOTHERAPY AND ONCOLOGY

Scale to Predict Survival After Surgery for Recurrent Glioblastoma Multiforme

(2010) John K. Park et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network

(2009) Michael Weller et al.   JOURNAL OF CLINICAL ONCOLOGY

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME

(2009) et al.   NEUROSURGERY

Identification of noninvasive imaging surrogates for brain tumor gene-expression modules

(2008) Maximilian Diehn et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma

(2007) Graziella Filippini et al.   NEURO-ONCOLOGY